GSK plc
GSK
#228
Rank
NZ$176.67 B
Marketcap
NZ$88.22
Share price
-1.98%
Change (1 day)
40.70%
Change (1 year)

EPS for GSK plc (GSK)

EPS in 2026 (TTM): NZ$6.64

According to GSK plc's latest financial reports the company's current EPS (TTM) is NZ$6.60. In 2025 the company made an earnings per share (EPS) of NZ$6.40 an increase over its 2024 EPS that were of NZ$2.71.

EPS history for GSK plc from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$6.643.66%
2025NZ$6.40136.36%
2024NZ$2.71-47.35%
2023NZ$5.15-64.2%
2022NZ$14.37182.29%
2021NZ$5.09-18.07%
2020NZ$6.2222.34%
2019NZ$5.0823.9%
2018NZ$4.10140.61%
2017NZ$1.7064.45%
2016NZ$1.04-90.61%
2015NZ$11.03178.12%
2014NZ$3.97-48.11%
2013NZ$7.6422.68%
2012NZ$6.23-11.31%
2011NZ$7.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$11.93 80.63%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.23-66.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.35-34.14%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$6.08-8.01%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$11.81 78.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$2.33-64.75%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
NZ-$0.54-108.23%๐Ÿ‡บ๐Ÿ‡ธ USA